Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention

Metabolic syndrome (MetS) is a major risk factor for cardiovascular disease and negatively affecting the prognosis of patients with ST elevation myocardial infarction (STEMI). Macrophage migration inhibitory factor (MIF) is a multipotent cytokine involved in various cardiovascular and inflammatory d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiao-Lin, Zhao, Qian, Liu, Fen, Yuan, Yu-Juan, Fang, Bin-Bin, Zhang, Xue-He, Li, Wen-Ling, Li, Xiao-Mei, Du, Guo-Li, Gao, Xiao-Ming, Yang, Yi-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403533/
https://www.ncbi.nlm.nih.gov/pubmed/36035926
http://dx.doi.org/10.3389/fcvm.2022.947395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403533/
https://www.ncbi.nlm.nih.gov/pubmed/36035926
http://dx.doi.org/10.3389/fcvm.2022.947395

Ejemplares similares